[ Price : $8.95]
FDA warns Chinas Jiangsu NHWA Pharmaceuticals about CGMP deviations in its manufacturing of active pharmaceutical ingredients.[ Price : $8.95]
FDA approves eight smokeless tobacco products under the new modified risk tobacco product pathway.[ Price : $8.95]
FDA accepts for review an IntelGenx 505(b)(2) NDA resubmission for Rizaport VersaFilm (rizatriptan ) an oral disintegrating film f...[ Price : $8.95]
FDA releases its latest batch of Warning Letters that includes Jiangsu NHWA Pharmaceutical Co. and Sofie Co.[ Price : $8.95]
Three stakeholders raise concerns with an FDA guidance on gastroparesis drug development.[ Price : $8.95]
FDA grants Garwood Medical a Breakthrough Device designation for its BioPrax device for eliminating biofilm infections on prosthet...[ Price : $8.95]
FDA approves a Vertex Pharmaceuticals NDA for Trikafta (elexacaftor/ivacaftor/tezacaftor), the first triple combination therapy to...